How to buy Australian Clinical Labs (ACL) shares
Learn how to easily invest in Australian Clinical Labs shares.
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Australian Clinical Labs Limited is a diagnostics & research business based in Australia. Australian Clinical Labs shares (ACL) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian Dollars. Australian Clinical Labs has a trailing 12-month revenue of around $646.7 million. If you're looking to buy shares, check out the steps below.
How to buy shares in Australian Clinical Labs
- Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
- Search for Australian Clinical Labs. Find the share by name or ticker symbol: ACL. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Australian Clinical Labs reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At today's price, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
- Check in on your investment. Congratulations, you own a part of Australian Clinical Labs. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
What's in this guide?
- Australian Clinical Labs key stats
- Compare share trading platforms
- Is Australian Clinical Labs stock a buy or sell?
- Australian Clinical Labs performance over time
- Are Australian Clinical Labs shares over-valued?
- Australian Clinical Labs's financials
- Does Australian Clinical Labs pay a dividend?
- Other common questions
Australian Clinical Labs stock price (ASX:ACL)Use our graph to track the performance of ACL stocks over time.
Australian Clinical Labs shares at a glance
|52-week range||$3.18 - $4.69|
|50-day moving average||$4.3503|
|200-day moving average||$3.9023|
|Dividend yield||$0.142 (3.09%)|
|Earnings per share (TTM)||$0.397|
Compare share trading platforms
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
Is it a good time to buy Australian Clinical Labs stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Australian Clinical Labs price performance over time
|1 week (2021-09-17)||2.24%|
|1 month (2021-08-24)||8.57%|
|3 months (2021-06-25)||26.67%|
Is Australian Clinical Labs under- or over-valued?
Valuing Australian Clinical Labs stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Australian Clinical Labs's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Australian Clinical Labs's P/E ratio
Australian Clinical Labs's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 11x. In other words, Australian Clinical Labs shares trade at around 11x recent earnings.
That's relatively low compared to, say, the P/E ratio for the ASX over the 12 months to December 2019 (32.14). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Australian Clinical Labs's EBITDA
Australian Clinical Labs's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $136.2 million (£0.0 million).
The EBITDA is a measure of a Australian Clinical Labs's overall financial performance and is widely used to measure a its profitability.
Australian Clinical Labs financials
|Revenue TTM||$646.7 million|
|Operating margin TTM||19.48%|
|Gross profit TTM||$520.2 million|
|Return on assets TTM||18.73%|
|Return on equity TTM||80.04%|
|Market capitalisation||$916.3 million|
TTM: trailing 12 months
Australian Clinical Labs share dividends
We're not expecting Australian Clinical Labs to pay a dividend over the next 12 months.
Australian Clinical Labs overview
Australian Clinical Labs Limited provides pathology services. The company offers various routine pathology tests, advanced pathology, first trimester screening and non-invasive prenatal testing, chemical pathology, hematology, histopathology, immunology, serology and microbiology, functional pathology, and commercial drug and alcohol testing services. The company offers its service to private and public hospitals. Australian Clinical Labs Limited was incorporated in 2020 and is based in Clayton, Australia.
Stocks similar to Australian Clinical Labs
Australian Clinical Labs in the news
Frequently asked questions
More guides on Finder
How to invest in the Cosmos Exploration IPO
Everything we know about the Cosmos Exploration IPO, plus information on how to buy in.
What is behind the bounce in the Zip Co share price?
Shares in BNPL provider Zip Co have slipped more than 13% in the last 6 months.
Why the AGL share price has rebounded today
Shares in electricity giant AGL Energy are down 60% in the last 12 months.
How to invest in the Dundas Minerals IPO
Everything we know about the Dundas Minerals IPO, plus information on how to buy in.
How to invest in the Kalgoorlie Gold Mining IPO
Everything we know about the Kalgoorlie Gold Mining IPO, plus information on how to buy in.
Why are the CBA and WBC share prices stumbling today?
Shares in the major banks have risen more than 50% in the last 12 months.
How to buy Evergrande shares from Australia
Steps to owning and managing China Evergrande Group shares from Australia.
How to invest in the Hamelin Gold IPO
Everything we know about the Hamelin Gold IPO, plus information on how to buy in.
How to invest in the Lykos Metals IPO
Everything we know about the Lykos Metals IPO, plus information on how to buy in.
Health insurance for podiatry
Find out the steps needed to find adequate cover, and give you an assurance that you won’t have to pay the full cost of your podiatric surgery.
Ask an Expert